Frontiers in Spatial Biology, Immunotherapy & Precision Medicine Bridging single-cell discovery, immune science, and clinical translation.
Save the Dates: February 25–27, 2027 Location: S31 Hotel, Bangkok, Thailand
The AP-SciBio 2027, in collaboration with the World Immunotherapy Council (WIC) Asia-Pacific Meeting and the Thai Immunology Annual Meeting, brings together global leaders in the fields of spatial biology and translational medicine.
Hosted in the heart of Bangkok, this symposium serves as a premier platform for researchers, clinicians, and industry experts to share breakthroughs in mapping the cellular architecture of life and advancing next-generation therapies.
1. Spatial & Single-Cell Frontier Focus: Mapping the cellular architecture of life with high-resolution spatial omics and AI. Keywords: Spatial Transcriptomics, Single-cell Sequencing, AI-driven Pathology.
2. Breakthroughs in Immunotherapy Focus: Advancing next-gen CAR-T cells, vaccines, and checkpoint inhibitors for global health. Keywords: Cell Therapy, Cancer Vaccines, Immune Checkpoints, Precision Oncology.
3. Bridging Molecular Immunology and Translational Medicine Focus: Advancing fundamental insights into immune signaling and cellular mechanisms. Keywords: Cytokine Signaling, Molecular Pathways, Clinical Translation, Immune Homeostasis.
Venue Information: S31 Sukhumvit Hotel 545 Sukhumvit Road, Khlong Toei Nuea, Bangkok 10110, Thailand Located in the vibrant Sukhumvit district, offering world-class facilities for international scientific exchange.
Partners & Organizations – AP-SciBio 2027 – WIC (World Immunotherapy Council) – Asia-Pacific Meeting – The Allergy, Asthma, and Immunology Association of Thailand (AAIAT) – Thailand Hub of Talents in Cancer Immunotherapy (TTCI) – PEACE Symposia Pacific Series
Join the Immuno-Revolution We invite researchers, clinicians, and biotech innovators from around the world to join us in Bangkok for this transformative event. Together, we will explore how spatial and single-cell insights are revolutionizing our understanding of tumor heterogeneity and immunotherapy outcomes.
Stay tuned to our website for upcoming details on session tracks, abstract submissions, and registration. For more information on the AP-SciBio series, visit www.ap-scibio.org
